Ron joined the company in 2016 as the Chief Financial Officer. Prior to INT, Ron was the Vice President of Biosensors International Group, a $300 million international medical device company, where he also served as General Manager of the U.S. R&D center overseeing the development of novel devices for the treatment of peripheral artery disease. Previously, Ron co-founded Verdant Medical, a start-up focused on treatments for peripheral artery disease (acquired by Biosensors). Ron also served as General Counsel and Corporate Secretary of XTENT, Inc., a NASDAQ-listed medical device company. Ron began his career as a practicing corporate and securities attorney with Silicon Valley Law Group where he focused on financings and M&A transactions for technology startups. Ron holds a Juris Doctor degree and a Masters of Business Administration degree from the University of Maine.